Researcher.Life Logo

Acta Pharmacologica Sinica : Impact Factor & More

eISSN: 1745-7254pISSN: 1671-4083

Key Metrics

CiteScore
11.3
Eigenfactor
0.005 - 0.01
H-Index
108
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Acta Pharmacologica Sinica

Acta Pharmacologica Sinica Journal Specifications

Overview
Publisher NATURE PUBL GROUP
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1980
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Acta Pharmacologica Sinica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Pharmacologica Sinica

Resibufogenin promotes angiogenesis via the VAV3-mediated ITGA5-VEGF signaling axis in macrophages to alleviate myocardial infarction.
  • 29 Apr 2026
  • Acta pharmacologica Sinica
Dopamine abrogates immunosuppression mediated by PD-L1 of cancer stem cells in a preclinical triple-negative breast cancer model.
  • 24 Apr 2026
  • Acta pharmacologica Sinica
Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition.
  • 23 Apr 2026
  • Acta pharmacologica Sinica
Inhibiting the transient receptor potential melastatin 2 channel in microglia: current evidence and therapeutic potential in neurological disorders.
  • 23 Apr 2026
  • Acta pharmacologica Sinica
Astrocytic apelin mediates cortical neuronal function and prevents anxiety-like behaviors in mice.
  • 10 Apr 2026
  • Acta pharmacologica Sinica
ADT-OH promotes mitophagy and suppresses the cytosolic mtDNA-cGAS-STING inflammatory cascade in microglia.
  • 9 Apr 2026
  • Acta pharmacologica Sinica
Resibufogenin promotes angiogenesis via the VAV3-mediated ITGA5-VEGF signaling axis in macrophages to alleviate myocardial infarction.
  • 29 Apr 2026
  • Acta pharmacologica Sinica
Dopamine abrogates immunosuppression mediated by PD-L1 of cancer stem cells in a preclinical triple-negative breast cancer model.
  • 24 Apr 2026
  • Acta pharmacologica Sinica
Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition.
  • 23 Apr 2026
  • Acta pharmacologica Sinica
Inhibiting the transient receptor potential melastatin 2 channel in microglia: current evidence and therapeutic potential in neurological disorders.
  • 23 Apr 2026
  • Acta pharmacologica Sinica
Astrocytic apelin mediates cortical neuronal function and prevents anxiety-like behaviors in mice.
  • 10 Apr 2026
  • Acta pharmacologica Sinica
ADT-OH promotes mitophagy and suppresses the cytosolic mtDNA-cGAS-STING inflammatory cascade in microglia.
  • 9 Apr 2026
  • Acta pharmacologica Sinica

FAQs on Acta Pharmacologica Sinica